Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03)
Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety of Neo-T in the treatment of
advanced solid tumors.
The secondary objective of this study is to evaluate preliminarily the effect of Neo-T in the
treatment of advanced solid tumors.